The relationship between the disposition and immunogenicity of sulfamethoxazole in the rat

Journal of Pharmacology and Experimental Therapeutics

Volumn 282, Issue 2, 1997, Pages 795-801

  Gill, Helen J ^a   Hough, Sally J ^a   Naisbitt, Dean J ^a   Maggs, James L ^a   Kitteringham, Neil R ^a   Pirmohamed, Munir ^a   Park, B Kevin ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; IMMUNOGLOBULIN G ANTIBODY; N4 ACETYLSULFAMETHOXAZOLE; SULFAMETHOXAZOLE; SULFAMETHOXAZOLE HYDROXYLAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG DISPOSITION; DRUG EXCRETION; DRUG HYPERSENSITIVITY; IMMUNOGENICITY; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIBODY SPECIFICITY; BIOTRANSFORMATION; DRUG HYPERSENSITIVITY; IMMUNOGLOBULIN G; MALE; RATS; RATS, WISTAR; SULFAMETHOXAZOLE;

EID: 0030792108     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. AUKRUST, P., SVARDAL, A. M., MULLER, F., LUNDEN, B., BERGE, R. K., UELAND, P. M. AND FROLAND, S. S.: Increased levels of oxidised glutathione in CD4+ lymphocytes associated with disturbed intracellular redox balance in human immunodeficiency virus type 1 infection. Blood 86: 258-267, 1995.
2. CARR, A., TINDALL, B., PENNY, R. AND COOPER, D. A.: In vitro cytotoxicity as a marker of hypersensitivity to sulphamethoxazole in patients with HIV. Clin. Exp. Immunol. 94: 21-25, 1993.
3. CARR, A. AND COOPER, D. A.: Pathogenesis and management of HIV-associated drug hypersensitivity. AIDS Clin. Rev. 96: 65-97, 1995.
4. CRIBB, A. E., MILLER, M., LEEDER, J. S., HILL, J. AND SPIELBERG, S. P.: Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione: Implications for idiosyncratic toxicity. Drug Metab. Dispos. 19: 900-906, 1991.
5. CRIBB, A. E., NAKAMURA, H., GRANT, D. M., MILLER, M. A. AND SPIELBERG, S. P.: Role of polymorphic and monomorphic human arylamine N-acetyl transferases in determining sulfamethoxazole metabolism. Biochem. Pharmacol. 45: 1277-1282, 1993.
6. 4-hydroxylation of sulfamethoxazole by cytochrome P450 of the cytochrome P4502C subfamily and reduction of sulfamethoxazole hydroxylamine in human and rat microsomes. Drug Metab. Dispos. 23: 406-414, 1995.
7. CRIBB, A. E., Nuss, C. E., ALBERTS, D. W., LAMPHERE, D. B., GRANT, D. M., GROSSMAN, S. J. AND SPIELBERG, S. P.: Covalent binding of sulfamethoxazole reactive metabolites to human and rat liver subcellular fractions assessed by immunochemical detection. Chem. Res. Toxicol. 9: 500-507, 1996.
8. DAFTARIAN, M. P., FILION, L. G., CAMERON W., CONWAY, B., ROY, R., TROPPER, F. AND DIAZ-MITOMA, F.: Immune response to sulfamethoxazole in patients with AIDS. Clin. Diagn. Lab. Immunol. 2: 199-204, 1995.
9. DORFMAN, L. E. AND SMITH, J. P.: Sulfonamide crystalluria: a forgotten disease. J. Urol. 104: 482-483, 1970.
10. ELLIS, M. K., HILL, S. AND FOSTER, P. M. D.: Reactions of nitrosonitrobenzenes with biological thiols: identification of glutathion-s-yl conjugates. Chem. Biol. Interact. 82: 151-163, 1992.
11. GILL, H. J., MAGGS, J. L., MADDEN, S., PIRMOHAMED, M. AND PARK, B. K.: The effect of fluconazole and ketoconazole on the metabolism of sulphamenthoxazole. Br. J. Clin. Pharmacol 42: 347-353, 1996.
12. JEWELL, H., MAGGS, J. L., HARRISON, A. C., O'NEILL, P. M., RUSCOE, J. E. AND PARK, B. K.: The role of hepatic metabolism in the bioactivation and detoxication of amodiaquine. Xenobiotica 25: 199-217, 1995.
13. JICK, H.: Adverse reactions to trimethoprim-sulfamethoxazole in hospitalized patients. Rev. Infect. Dis. 4: 426-428, 1982.
14. KOOPMANS, P. P., VAN DER VEN, A. J. A. M., VREE, T. B, AND VAN DER MEER, J. W. M.: Pathogenesis of hypersensitivity reactions to drugs in patients with HIV infection: Allergic or toxic? AIDS 9: 217-222, 1995.
15. LAWSON, D. H. AND PAICE, B. J.: Adverse reactions to trimethoprim-sulfamethoxazole. Rev. Infect. Dis. 4: 429-433, 1982.
16. LEE, B. L., WONG, D., BENOWITZ, N. L. AND SULLAM P. M.: Altered patterns of drug metabolism in patients with acquired immunodeficiency syndrome. Clin. Pharmacol. Ther. 53: 529-535, 1993.
17. MADDEN, S., MAGGS, J. L. AND PARK, B. K.: Bioactivation of carbamazepine in the in vivo: evidence for the formation of reactive arene oxide(s). Drug Metab. Dispos. 24: 469-479, 1996.
18. MAGGS, J. L., WILLIAMS, D., PIRMOHAMED, M. AND PARK, B. K.: The metabolic formation of reactive intermediates from clozapine, a drug associated with agranulocytosis in man. J. Pharmacol. Exp. Ther. 275: 1463-1475, 1995.
19. MAURI-HELLWEG, D., BETTENS, F., MAURI, D., BRANDER, C., HUNZIKER, T. AND PICHLER, W. J.: Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine. J. Immunol. 155: 462-472, 1995.
20. MEEKINS, C. V., SULLIVAN, T. J. AND GRUCHALLA, R. S.: Immunochemical analysis of sulphonamide drug allergy: identidcation of sulfamethoxazole-substituted human serum proteins. J. Allergy Clin. Immunol. 94: 1017-1024, 1994.
21. NAISBITT, D. J., O'NEILL, P. M., PIRMOHAMED, M. AND PARK, B. K.: Synthesis and reactions of nitroso sulphamethoxazole with biological nucleophiles: Implications for immune mediated toxicity. Bioorg. Med. Chem. Lett. 6: 1511-1516, 1996.
22. + subjects reporting adverse reactions to sulfamethoxazole. Int. Arch. Allergy Appl. Immunol. 94: 246-247, 1991.
23. PIRMOHAMED, M. AND PARK, B. K.: Drug reactions in HIV-infected patients. Postgrad. Doctor 18: 438-444, 1995.
24. PIRMOHAMED, M., WILLIAMS, D., TINGLE, M. D., BARRY, M., KHOO, S., O'MAHONY, C., WILKINS, E., BRECKENRIDGE, A. M. AND PARK, B. K.: Intracellular glutathione in the peripheral blood cells of HIV-infected patients: failure to show a deficiency. AIDS 10: 501-507, 1996.
25. RIEDER, M. J., UETRECHT, J., SHEAR, N. H. AND SPIELBERG, S. P.: Synthesis and in vitro toxicity of hydroxylamine metabolites of sulfonamides. J. Pharmacol. Exp. Ther. 244: 724-728, 1988.
26. RIEDER, M. J., UETRECHT, J., SHEAR, N. H. CANNON, M., MILLER, M. AND SPIELBERG, S.P.: Diagnosis of sulfonamide hypersensitivity reactions by in vitro 'rechallenge' with hydroxylamine metabolites. Ann. Intern. Med. 110: 286-289, 1989.
27. RIEDER, M. J., SHEAR, N. H., KANEE, A., TANG, B. K. AND SPIELBERG, S. P.: Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions. Clin. Pharmacol. Ther. 49: 13-17, 1991.
28. RIEDER, M. J., KRAUSE, R., BIRD, I. A. AND DEKABAN, G. A.: Toxicity of sulfonamide-reactive metabolites in HIV-infected, HTLV-infected, and noninfected cells. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 8: 134-140, 1995a.
29. RIEDER, M. J., KRAUSE, R. AND BIRD, I. A.: Time-course of toxicity of reactive sulfonamide metabolites. Toxicology 95: 141-146, 1995b.
30. RILEY, R. J., CRIBB, A. E. AND SPIELBERG, S. P.: Glutathione transferase μ deficiency is not a marker for predisposition to sulphonamide toxicity. Biochem. Pharmacol. 42: 696-698, 1991.
31. SHEAR, N. H., SPIELBERG, S. P., GRANT, D. M., TANG, B. K. AND KALOW, W.: Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity. Ann. Intern. Med. 105: 179-184, 1986.
32. SORRISO, S.: Structural chemistry. In The Chemistry of Amino, Nitroso and Nitro Compounds and Their Derivatives, ed. by S. Patai, pp. 1-51, J Wiley & Sons, Chichester, 1982.
33. TSCHACHLER, E., BERGSTRESSER, P. R. AND STINGL, G.: HIV-related skin diseases. Lancet 348: 659-663, 1996.
34. VAN DER VEN, A. J. A. M., KOOPMANS, P. P., VREE, T. B., VAN DER MEER, J. W.: Adverse reactions to co-trimoxazole in HIV infection. Lancet ii: 431-433, 1991.
35. 1-glucuronide conjugates in healthy human volunteers. Clin. Drug Invest. 9: 43-53, 1995.
36. WOLKENSTEIN, P., CARRIERE, V., CHARUE, D., BASTUJI-GARIN, S., REVUZ, J., BEAUNE, P. AND BAGOT, M.: A slow acetylator genotype is a risk factor for sulphonamide-induced toxic epidermal necrolysis and Stevens-Johnson syndrome. Pharmacogenetics 5: 255-258, 1995.